Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 17/04/2008

    Targeted gene replacement in barley

    The GABI-PRECISE consortium which originates from the Genome Analysis of the Plant Biological System GABI initiative has announced a cooperative project on the introduction of gene targeting in barley.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/targeted-gene-replacement-in-barley
  • Press release - 17/04/2008

    BioLux GmbH - from the hen to the egg and then to the clients

    It began as a service laboratory for DNA sequencing and within a few years became a worldwide network of highly specialised biotech companies for molecular biology products. Investments in platform technologies play a key role in this development. Since then the team at Stuttgart-based BioLux GmbH has found that the production of antibodies is its highest revenue business activity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/biolux-gmbh-from-the-hen-to-the-egg-and-then-to-the-clients
  • Article - 16/04/2008

    Roland Schuele - "Research cannot be predicted"

    Professor Roland Schuele from the University Womens Hospital in Freiburg originally studied biochemistry. Nowadays Schuele is researching the development of prostate cancer. During his scientific career he has learnt that research cannot be steered in a particular direction. It develops and we follow it said Schuele who has been able to gain astonishing insights into the molecular processes in tumour cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/roland-schuele-research-cannot-be-predicted
  • Press release - 16/04/2008

    Effective Cancer Immune Therapy Through Order in the Blood Vessels

    Researchers at the German Cancer Research Center have discovered a key molecule that is responsible for the immature structure of blood vessels in malignant tumors. If this molecule is switched off in mice vessels normalize so that immune cells are better able to get to the tumor tissue.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/effective-cancer-immune-therapy-through-order-in-the-blood-vessels
  • Press release - 14/04/2008

    "Make or break"

    The moral theologian from Freiburg Eberhard Schockenhoff is a self-styled protector of life but so is the stem cell researcher Marcel Leist from the University of Constance. The two men clashed at a recent debate on the use of embryonic stem cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/make-or-break
  • Article - 14/04/2008

    Molecular cell recognition - putting the brain in order

    The neurogeneticists in the group of Professor Karl-Friedrich Fischbach at the University of Freiburg are investigating how the complex optical areas of the brain are organised. They found that proteins form a functional unit.

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-cell-recognition-putting-the-brain-in-order
  • Press release - 13/04/2008

    Landesstiftung foundation sets a new course

    The supervisory board of the Landesstiftung foundation has agreed to fund new projects and programmes with a total of 32.7 million euros in 2008. The board has agreed on new research and education priorities.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/landesstiftung-foundation-sets-a-new-course
  • Article - 13/04/2008 Liver tumour with vessels during the treatment with microspheres (Photo: Mannheim University Hospital)

    Selective internal radiotherapy

    Since early 2008 the Institute of Clinical Radiology and Nuclear Medicine at Mannheim University Hospital has been offering a new therapy for the treatment of liver cancers selective internal radiotherapy SIRT.

    https://www.gesundheitsindustrie-bw.de/en/article/news/selective-internal-radiotherapy
  • Article - 13/04/2008

    Scientists discover a genetic dependence to nicotine

    Scientists have shown that a particular variant of a receptor gene impacts smoking behaviour and hence confers a 30 increase in risk of lung cancer and a 20 increase in risk of peripheral artery disease PAD.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/scientists-discover-a-genetic-dependence-to-nicotine
  • Article - 12/04/2008

    Each digit can be moved individually

    A new prosthetic hand is being tested at the University Hospital of Heidelberg. The hand can hold a bank card the forefinger can operate a keyboard and lift a bag weighing up to 20 kg. A patient at the Orthopaedic Hospital at Heidelberg University has now tested the i-Limb-Hand.

    https://www.gesundheitsindustrie-bw.de/en/article/news/each-digit-can-be-moved-individually
  • Article - 12/04/2008

    Genetic testing: binding consultation to become central element

    The benchmark paper on the Genetic Diagnostics Act which has long been heralded by the governing coalition foresees the binding counselling of people concerned. The coalition is opposed to allowing employers to require their employees to undergo genetic tests.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-testing-binding-consultation-to-become-central-element
  • Press release - 11/04/2008

    German Bundestag relaxes Stem Cell Act

    The German parliament voted on Friday 11th April 2008 in favour of changes allowing the import of stem cells of embryos taken before 1st May 2007. This inreases the number of stem cell lines available to German researchers from 21 to almost 500.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-bundestag-relaxes-stem-cell-act
  • Article - 08/04/2008 Portrait of professor doctor Michael Frotscher

    Michael Frotscher - "Creativity is of great importance to me"

    According to Professor Michael Frotscher from the University of Freiburg German research does not lack money or good researchers what it lacks most is time. Researchers in leading positions have to deal with huge amounts of administrative work reducing the time they can spend on creative inspiration. Frotscher thrives on creative challenges. He actually fled from the former East Germany because he could not develop his ideas freely during his…

    https://www.gesundheitsindustrie-bw.de/en/article/news/michael-frotscher-creativity-is-of-great-importance-to-me
  • Press release - 08/04/2008

    Boehringer Ingelheim continues to grow

    Boehringer Ingelheim enjoyed continued success in 2007 and its growth is outpacing the pharmaceuticals market for the eighth year in a row. The companys turnover rose by 8.8 in local currency to almost EUR 11 billion.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/boehringer-ingelheim-continues-to-grow
  • Article - 07/04/2008

    Bacteriophages fighting against wound infections

    The increasing number of bacteria that are resistant to antibiotics is becoming a great problem in the treatment of infected wounds. The Hohenstein Institutes are developing novel wound dressings that use bacteriophages to combat even the most virulent pathogens.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bacteriophages-fighting-against-wound-infections
  • Article - 06/04/2008 Chlamydomonas Rheinhardii Kl

    Molecular chaperons in algal chloroplasts

    Michael Schroda from the Department of Plant Biochemistry at the University of Freiburg is examining the role of HSP70B a chaperon in the chloroplasts of Chlamydomonas reinhardtii algae which is important for protecting the algae against high light intensity.

    https://www.gesundheitsindustrie-bw.de/en/article/news/molecular-chaperons-in-algal-chloroplasts
  • Press release - 05/04/2008 Hezinger Algaetec Logo

    Hezinger Algaetec: Bio-diesel should soon become cheaper

    The system exporter Hezinger GmbH wants to act in future as a global supplier of photobioreactors for the breeding of algae in order to promote the extraction of bio-diesel from the vegetable oil of algae as an alternative to the use of wheat rapeseed and maize.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hezinger-algaetec-bio-diesel-should-soon-become-cheaper
  • Article - 05/04/2008

    Successful cooperation between science and industry (II)

    In the second article in the series on the platforms successful cooperations BioValley presents an encouraging approach for improving the quality of life of severely ill cancer patients and the successful establishment of an industrial biochip platform.

    https://www.gesundheitsindustrie-bw.de/en/article/news/successful-cooperation-between-science-and-industry-ii
  • Article - 04/04/2008

    Genetic barcode to unmask environmental toxins

    In their early developmental stages living organisms are very sensitive to exposure to chemicals. Scientists at the KIT Institute of Toxicology and Genetics ITG have developed a model system with fish embryos to specifically identify the effects of environmental toxins at a very early point.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-barcode-to-unmask-environmental-toxins
  • Article - 04/04/2008

    Cell models for human hearts wanted

    A consortium of two universities two applied research institutes and a research-based pharmaceutical company is looking for innovative cellular models of the human heart with the aim of developing better methods for drug testing.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cell-models-for-human-hearts-wanted
  • Article - 31/03/2008 Biopharmaceuticals are not as easy to engineer as chemical substances. (Photo: ratiopharm)

    First biosimilar from Ulm close to approval

    ratiopharm Germanys second largest generics producer received a positive assessment from the EU regulatory body EMEA in London for the first filgrastim biosimilar. The company expects to receive marketing authorisation for its first biosimilar by mid to end April.

    https://www.gesundheitsindustrie-bw.de/en/article/news/first-biosimilar-from-ulm-close-to-approval
  • Article - 31/03/2008

    "Nanomedicine will be able to combat incurable diseases"

    The first European Conference for Clinical Nanomedicine is to be held soon in Basel. BIOPRO has therefore discussed this promising area of application with Beat Löffler and Dr. Patrick Hunziker the founders of the European Foundation for Clinical Nanomedicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nanomedicine-will-be-able-to-combat-incurable-diseases
  • Article - 30/03/2008 When the gate is open (left), a sufficient quantity of water molecules is available in order to envelop the ions that are seeking to diffuse through the channel. If the gate is closed (right), the diameter of the pore decreases and the water molecules are

    Small air bubbles with a huge impact

    Scientists from the Max Planck Institute for Metal Research in Stuttgart and their colleagues from Chicago and Miami have identified a physical mechanism that gives a new explanation as to how ion channels work.

    https://www.gesundheitsindustrie-bw.de/en/article/news/small-air-bubbles-with-a-huge-impact
  • Article - 30/03/2008

    Merckle withdraws family from business operations

    The Swabian businessman Adolf Merckle has reorganised his company empire and withdrawn all family members from business operations. This affects the head of the Ulm-based ratiopharm business Philipp Daniel Merckle.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/merckle-withdraws-family-from-business-operations
  • Article - 30/03/2008

    Hartmann looks back on a successful 2007

    The Heidenheim based Hartmann Group increased its sales growth by 5.3 to EUR 1.28 billion in 2007. According to Rinaldo Riguzzi CEO of Paul Hartmann AG consolidated net income rose 14 to EUR 38.8 million.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hartmann-looks-back-on-a-successful-2007

Page 113 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search